CVS Health Corp.

  • Market Cap: Large Cap
  • Industry: Retailing
  • ISIN: US1266501006
USD
90.55
3.19 (3.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,00,442.00
1,05,678.00
1,02,882.00
98,942.00
94,609.00
97,504.00
95,409.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,00,442.00
1,05,678.00
1,02,882.00
98,942.00
94,609.00
97,504.00
95,409.00
Raw Material Cost
84,802.00
92,126.00
89,065.00
85,322.00
80,192.00
84,811.00
82,870.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
29,358.00
33,066.00
32,020.00
31,317.00
29,135.00
29,543.00
29,922.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
774.00
769.00
767.00
768.00
779.00
754.00
746.00
Selling and Distribution Expenses
10,932.00
11,235.00
10,858.00
10,306.00
10,343.00
10,481.00
10,516.00
Other Expenses
-3,013.20
-3,383.50
-3,278.70
-3,208.50
-2,991.40
-3,029.70
-3,066.80
Total Expenditure (Excl Depreciation)
95,734.00
1,03,361.00
99,923.00
95,628.00
90,535.00
95,292.00
93,386.00
Operating Profit (PBDIT) excl Other Income
4708
2317
2959
3314
4074
2212
2023
Other Income
16.00
26.00
481.00
7.00
1.00
227.00
38.00
Operating Profit (PBDIT)
5,839.00
3,490.00
4,574.00
4,492.00
5,229.00
3,586.00
3,222.00
Interest
774.00
769.00
767.00
768.00
779.00
754.00
746.00
Exceptional Items
-12.00
-220.00
-6,155.00
-906.00
-679.00
441.00
-1,210.00
Gross Profit (PBDT)
15,640.00
13,552.00
13,817.00
13,620.00
14,417.00
12,693.00
12,539.00
Depreciation
1,115.00
1,147.00
1,134.00
1,171.00
1,154.00
1,147.00
1,161.00
Profit Before Tax
3,938.00
1,354.00
-3,482.00
1,647.00
2,617.00
2,126.00
105.00
Tax
981.00
-1,569.00
508.00
634.00
835.00
503.00
34.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,943.00
2,943.00
-3,975.00
1,021.00
1,779.00
1,644.00
87.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,943.00
2,943.00
-3,975.00
1,021.00
1,779.00
1,644.00
87.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
14.00
-20.00
-15.00
-8.00
3.00
-21.00
-16.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,957.00
2,923.00
-3,990.00
1,013.00
1,782.00
1,623.00
71.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
77,456.00
75,214.00
72,928.00
77,379.00
76,929.00
75,560.00
74,944.00
Earnings per share (EPS)
2.3
2.3
-3.13
0.8
1.41
1.3
0.07
Diluted Earnings per share
2.3
2.3
-3.13
0.8
1.41
1.3
0.07
Operating Profit Margin (Excl OI)
4.69%
2.19%
2.88%
3.35%
4.31%
2.27%
2.12%
Gross Profit Margin
5.03%
2.37%
-2.28%
2.85%
3.99%
3.36%
1.33%
PAT Margin
2.93%
2.78%
-3.86%
1.03%
1.88%
1.69%
0.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 6.17% vs 6.96% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 65.94% vs 58.54% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 11.38% vs 45.75% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -0.64% vs 9.72% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of CVS Health Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,00,442.00
5,646.08
94,795.92
1,678.97%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,00,442.00
5,646.08
94,795.92
1,678.97%
Raw Material Cost
84,802.00
4,550.48
80,251.52
1,763.58%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
29,358.00
0.00
29,358.00
Power Cost
0
0
0.00
Manufacturing Expenses
774.00
72.66
701.34
965.24%
Selling and Distribution Expenses
10,932.00
1,167.72
9,764.28
836.18%
Other Expenses
-3,013.20
-7.27
-3,005.93
-41,347.04%
Total Expenditure (Excl Depreciation)
95,734.00
5,718.20
90,015.80
1,574.20%
Operating Profit (PBDIT) excl Other Income
4,708.00
-72.12
4,780.12
6,628.01%
Other Income
16.00
24.09
-8.09
-33.58%
Operating Profit (PBDIT)
5,839.00
21.00
5,818.00
27,704.76%
Interest
774.00
72.66
701.34
965.24%
Exceptional Items
-12.00
-886.76
874.76
98.65%
Gross Profit (PBDT)
15,640.00
1,095.60
14,544.40
1,327.53%
Depreciation
1,115.00
69.03
1,045.97
1,515.24%
Profit Before Tax
3,938.00
-1,007.46
4,945.46
490.88%
Tax
981.00
2.34
978.66
41,823.08%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
2,943.00
-1,009.79
3,952.79
391.45%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,943.00
-1,009.79
3,952.79
391.45%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
14.00
0.00
14.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,957.00
-1,009.79
3,966.79
392.83%
Equity Capital
0
0
0.00
Face Value
0.01
1.00
0.00
Reserves
77,456.00
-1,908.18
79,364.18
4,159.16%
Earnings per share (EPS)
2.30
-18.26
20.56
112.60%
Diluted Earnings per share
2.30
-18.26
20.56
112.60%
Operating Profit Margin (Excl OI)
4.69%
-1.28%
0.00
5.97%
Gross Profit Margin
5.03%
-16.62%
0.00
21.65%
PAT Margin
2.93%
-17.88%
0.00
20.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 10,044.20 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -4.95% vs 2.72% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 6.17% vs 6.96% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 295.70 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 1.16% vs 173.26% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 65.94% vs 58.54% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 582.30 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 68.10% vs -15.37% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 11.38% vs 45.75% in Mar 2025

Quarterly - Interest
Interest 77.40 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.65% vs 0.26% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -0.64% vs 9.72% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.69%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025